Assessing Bio-Techne (TECH) Valuation After Institutional Buying Earnings Beat And New AI Drug Discovery Push [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
Bio-Techne (TECH) is back in focus after institutional investors such as Jefferies Financial Group and Madison Investments increased their exposure, alongside earnings that topped expectations and fresh AI collaborations in drug discovery. See our latest analysis for Bio-Techne. Despite upbeat earnings and fresh AI partnerships, Bio-Techne's recent share price performance has been weak, with a 30 day share price return of a 19.9% decline and a 1 year total shareholder return of a 17.7% loss. This suggests that sentiment has yet to fully reflect the renewed institutional interest and new CEO plan. If AI enabled drug discovery is on your radar, this could be a good moment to scan the wider opportunity set through our list of 33 healthcare AI stocks With Bio-Techne shares down over the past year despite earnings beating expectations and institutional buyers stepping in, the key question is whether today's US$50.85 price undervalues its prospects or already reflects growth that i
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? [Yahoo! Finance]Yahoo! Finance
- What Makes Bio-Techne Corporation (TECH) a Good Investment? [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Corporation (TECH) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Exosome Diagnostic and Therapeutics Market to Reach USD 401.70 Million by 2032 Amid Rapid Advances in Liquid Biopsy, Precision Medicine, and Exosome-Based Drug Delivery - Credence Research [Yahoo! Finance]Yahoo! Finance
TECH
Earnings
- 2/4/26 - Beat
TECH
Sec Filings
- 3/4/26 - Form 3
- 3/4/26 - Form 4
- 2/19/26 - Form 4
- TECH's page on the SEC website